|Articles|August 1, 2018
- Pharmaceutical Executive-08-01-2018
- Volume 38
- Issue 8
Pharmaceutical Executive, August 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive August 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 8 years ago
Emerging Biotech: Innovation, Location, and Inspirationalmost 8 years ago
Cross-Border Funding in the Life Sciencesalmost 8 years ago
Face It. You’re Not a Biotech Anymorealmost 8 years ago
The Pulse of Biopharma M&Aalmost 8 years ago
The Big Apple’s Fresh Start in Biotechalmost 8 years ago
‘Emerging’ Product Launch Strategiesalmost 8 years ago
Biotech Investment: Reigning in Spainalmost 8 years ago
Traditional Scientific Search is Brokenalmost 8 years ago
Tough Fight Looms in Preserving R&D Incentivesalmost 8 years ago
From Science to SuccessAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pharma M&A Roundup: Servier Acquiring Edgewise Therapeutics' Muscular Dystrophy Business, Hanmi Enters Licensing Agreement with Eli Lilly, Avenzo Enters Merger Agreement with Rallybio
2
FDA Approves Xocova as First Oral Post-Exposure Covid-19 Prevention Therapy
3
CVS Restores Coverage of Lilly’s Zepbound, Adds Oral Obesity Drug Foundayo
4
Why Breakthrough Cell and Gene Therapies Still Fail at the Finish Line
5